Regeneron (REGN) Tops Q3 EPS by 132c
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $612.50 --0%
Revenue Growth %: +3.8%
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +3.8%
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q3 EPS of $11.14, $1.32 better than the analyst estimate of $9.82. Revenue for the quarter came in at $2.94 billion versus the consensus estimate of $2.94 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG)
- Jefferies Reinstates Talen Energy (TLN) at Hold
- AeroVironment restates quarterly financials, citing $89M goodwill error
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
